Quthero is a Toronto biotech discovering and developing applications for tissue regeneration using its patented Q-peptide technology. The Q-peptide platform is designed to facilitate complete regeneration of a patient’s natural tissue with minimal scarring. Led by President and CEO Milica Radisic, PhD, the company offers products for direct purchase via its website and through participating physicians. Quthero raised new funding to support expansion and continued development efforts. The company raised $500K in funding plus an $850K co-investment for a total round size of $1.35M, with participation from the Ontario Centre of Innovation’s Life Science Innovation Fund.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2024